Try our Advanced Search for more refined results

Analysis

Breaking Down 3 New Senate Bills Targeting Drug Prices

By Ryan Davis (April 18, 2019, 7:36 PM EDT) -- Three bills were introduced in the Senate last week that sponsors say aim to lower drug prices by speeding up approval of generic drugs, including by limiting stays of generic drug approvals tied to Hatch-Waxman Act patent cases. Here's a look at how the bills would work....

Law360 is on it, so you are, too.

A Law360 subscription puts you at the center of fast-moving legal issues, trends and developments so you can act with speed and confidence. Over 200 articles are published daily across more than 60 topics, industries, practice areas and jurisdictions.


A Law360 subscription includes features such as

  • Daily newsletters
  • Expert analysis
  • Mobile app
  • Advanced search
  • Judge information
  • Real-time alerts
  • 450K+ searchable archived articles

And more!

Experience Law360 today with a free 7-day trial.

Start Free Trial

Already a subscriber? Click here to login

Attached Documents

Related Sections

Companies

Government Agencies

Hello! I'm Law360's automated support bot.

How can I help you today?

For example, you can type:
  • I forgot my password
  • I took a free trial but didn't get a verification email
  • How do I sign up for a newsletter?
Ask a question!